Erratum: Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils (J Infect Dis (2016) 214 (722–31) DOI: 10.1093/infdis/jiw230);Live attenuated influenza vaccine in children induces b-cell responses in tonsils

Journal of Infectious Diseases

Volumn 214, Issue 5, 2016, Pages 722-731

  Mohn, Kristin Greve Isdahl ^a   Brokstad, Karl Albert ^b   Pathirana, Rishi D ^a   Bredholt, Geir ^a   Jul Larsen, Åsne ^a   Trieu, Mai Chi ^a   Lartey, Sarah Larteley ^a   Montemoli, Emanuele ^e,f   Tøndel, Camilla ^a,c   Aarstad, Hans Jørgen ^a,c   Cox, Rebecca Jane ^a,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b Broegelmann Research Laboratory   (Norway)

^c Department of Pediatrics ^*  (United States)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF SIENA   (Italy)

^f VisMederi Srl   (Italy)

Author keywords

Antibody secreting cell; Humoral; LAIV; Longevity; Lymphoid tissue; Memory B cell; Mucosa; Pediatric; influenza; Saliva immune response; Tonsils

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; LIVE VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY SECRETING CELL; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CELL COUNT; CHILD; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA A (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA B VIRUS; INFLUENZA VACCINATION; LONGEVITY; MALE; MEMORY CELL; NORWEGIAN (PEOPLE); PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; SALIVA; SEROLOGY; TONSIL; TONSILLECTOMY; TREATMENT OUTCOME; VIRUS STRAIN; ANTIGEN PRESENTING CELL; BLOOD; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; PALATINE TONSIL; PRESCHOOL CHILD;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ANTIBODIES, VIRAL; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BLOOD; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOGLOBULIN A; INFLUENZA VACCINES; MALE; PALATINE TONSIL; SALIVA; VACCINES, ATTENUATED;

EID: 84988935846     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/INFDIS/JIW424     Document Type: Erratum

References (35)

1. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25:5086-96.
2. Sridhar S, Brokstad KA, Cox RJ. Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines. Vaccines (Basel) 2015; 3:373-89.
3. Jefferson T, Rivetti A, Di Pietrantonj C, Demicheli V, Ferroni E. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2012; 8: CD004879.
4. Jefferson T, Di Pietrantonj C, Rivetti A, Bawazeer GA, Al-Ansary LA, Ferroni E. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev 2010; doi:10.1002/14651858.CD001269.pub4.
5. Cha TA, Kao K, Zhao J, Fast PE, Mendelman PM, Arvin A. Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. J Clin Microbiol 2000; 38:839-45.
6. Bandell A, Woo J, Coelingh K. Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference. Expert Rev Vaccines 2011; 10:1131-41.
7. Brandtzaeg P. Immune functions of nasopharyngeal lymphoid tissue. Adv Otorhinolaryngol 2011; 72:20-4.
8. Clements ML, Murphy BR. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol 1986; 23:66-72.
9. Perry ME. The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat 1994; 185 (Pt 1):111-27.
10. Howie AJ. Scanning and transmission electron microscopy on the epithelium of human palatine tonsils. J Pathol 1980; 130:91-8.
11. Brandtzaeg P. Immunology of tonsils and adenoids: everything the ENT surgeon needs to know. Int J Pediatr Otorhinolaryngol 2003; 67(pl 1):S69-76.
12. >+< and CD8+ T cells from tonsillar tissue. Clin Exp Immunol 2012; 168:200-6.
13. Mohn KG, Bredholt G, Brokstad KA, et al. Longevity of B-Cell and T-Cell Responses After Live Attenuated Influenza Vaccination in Children. J Infect Dis 2014; 211:1541-9.
14. Brokstad KA, Cox RJ, Olofsson J, Jonsson R, Haaheim LR. Parenteral influenza vaccination induces a rapid systemic and local immune response. J Infect Dis 1995; 171:198-203.
15. el-Madhun AS, Cox RJ, Soreide A, Olofsson J, Haaheim LR. Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination. J Infect Dis 1998; 178:933-9.
16. Sasaki S, He XS, Holmes TH, et al. Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 2008; 3:e2975.
17. Cox RJ, Madhun AS, Hauge S, et al. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine 2009; 27:1889-97.
18. Madhun AS, Akselsen PE, Sjursen H, et al. An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. Vaccine 2010; 29:266-73.
19. Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994; 12:993-9.
20. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004; 286:111-22.
21. Committee for proprietary medicinal products CPMP EMa. Note for guidance on harmonisation of requriements for influenza vaccines. 1997.
22. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004; 25:570-7.
23. Renegar KB, Small PA Jr, Boykins LG, Wright PF. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 2004; 173:1978-86.
24. van Riet E, Ainai A, Suzuki T, Hasegawa H. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. Vaccine 2012; 30:5893-900.
25. Johnson PR Jr, Feldman S, Thompson JM, Mahoney JD, Wright PF. Comparison of long-term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine. J Med Virol 1985; 17: 325-35.
26. Clements ML, Betts RF, Tierney EL, Murphy BR. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus. J Clin Microbiol 1986; 24:157-60.
27. Chung JR, Flannery B, Thompson MG, et al. Seasonal Effectiveness of live attenuated and inactivated influenza vaccine. Pediatrics 2016; 137:1-10.
28. Potter CW. A history of influenza. J Appl Microbiol 2001; 91:572-9.
29. de Vinuesa CG, Cook MC, Ball J, et al. Germinal centers without T cells. J Exp Med 2000; 191:485-94.
30. Lee FE, Falsey AR, Halliley JL, Sanz I, Walsh EE. Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults. J Infect Dis 2010; 202:1659-66.
31. Purtha WE, Tedder TF, Johnson S, Bhattacharya D, Diamond MS. Memory B cells, but not long-lived plasma cells, possess antigen specificities for viral escape mutants. J Exp Med 2011; 208:2599-606.
32. Dogan I, Bertocci B, Vilmont V, et al. Multiple layers of B cell memory with different effector functions. Nat Immunol 2009; 10:1292-9.
33. Pape KA, Taylor JJ, Maul RW, Gearhart PJ, Jenkins MK. Different B cell populations mediate early and late memory during an endogenous immune response. Science 2011; 331:1203-7.
34. Wrammert J, Koutsonanos D, Li GM, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011; 208:181-93.
35. Toellner KM, Jenkinson WE, Taylor DR, et al. Low-level hypermutation in T cellindependent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med 2002; 195:383-9.